|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：D193602 |
| 產(chǎn)品名稱：Dasatinib-d8 |
| 產(chǎn)品CAS：1132093-70-9 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
D193602 |
| 名稱: |
Dasatinib-d8 |
| 別名: |
N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl-d8]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS-354825-d8; |
| CAS號(hào): |
1132093-70-9 |
| 參考CAS號(hào): |
類似: 302962-49-8 |
| 分子式: |
C??H??D?ClN?O?S |
| 外觀: |
白色至Light Tan Solid |
| 熔點(diǎn): |
>250ºC (dec.) |
| 分子量: |
496.05 |
| 儲(chǔ)存: |
-20ËšC Freezer |
| 溶解性: |
DMSO (Slightly), Methanol (Slightly) |
| 種類: |
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
